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Background: Avian metapneumovirus subtype C (aMPV/C) causes severe upper respiratory disease in turkeys.
Previous report revealed the presence of aMPV/C in wild birds in the southeast regions of the U.S.
Methods: In this study, aMPV/C positive oral swabs from American coots (AC) and Canada geese (CG) were
passaged three times in the respiratory tract of specific pathogen free (SPF) turkeys and used as aMPV/C P3 virus
isolates in subsequent studies.
Results: Wild bird P3 isolates showed similar growth characteristics when compared to virulent aMPV/C in chicken
embryo fibroblast ( CEF) cell cultures and their glycoprotein G gene sequence was closely related to the G gene of
aMPV/C Colorado reference virus. Three-day-old commercial or SPF turkeys were inoculated oculonasally with wild
bird aMPV/C P3 isolates. At 5 and 7 days post-inoculation (DPI), severe clinical signs were observed in both of the
AC and CG virus-exposed groups. Viral RNA was detected in tracheal swabs by reverse transcriptase polymerase
chain reaction (RT-PCR). In addition, immunohistochemistry showed virus replication in the nasal turbinate and
trachea. All virus-exposed turkeys developed positive antibody response by 14 DPI.
Conclusions: Our data demonstrate that aMPV/C wild bird isolates induced typical aMPV/C disease in the domestic
turkeys.
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Avian metapneumovirus (aMPV), previously known as
turkey rhinotracheitis virus (TRTV), is the cause of se-
vere respiratory infection in turkeys [1-4] and may also
be the etiologic agent of “swollen head syndrome (SHS)”
of chickens [2]. Originally identified in South Africa in
the late 1970s [5], aMPV later spread to Europe, Asia,
and South America [4,6-11]. aMPV/C was first isolated
in the United States during 1996 in Colorado [12,13]
and subsequently outbreaks were reported in Minnesota
[14] where the disease has emerged as a major economic
problem for the turkey industry. The virus has also
spread to other states, such as North Dakota, South
Dakota, Iowa, and Wisconsin [15]. aMPV is now consid-
ered a major disease threat in both turkeys and chickens
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reproduction in any medium, provided the oraMPV is a member of the genus Metapneumovirus in
the subfamily Pneumovirinae of the family Paramyxovir-
idae [16]. Members of the genus Metapneumovirus con-
tain a nonsegmented, single-stranded negative sense
RNA genome with the gene order 3’-leader-N-P-M-F-
M2-SH-G-L-trailer-5’ [17-22]. The aMPV isolates that
exist worldwide are currently classified into four sub-
types, namely, subtypes A, B, C, and D. This classifica-
tion is based on sequence divergence in the attachment
(G) glycoprotein and the antigenic differences observed
among aMPV strains. The US isolates belong to subtype
C [23,24], while the majority of aMPVs isolated in
Europe, Asia, and South America belong to the subtype
A or B [6,25,26]. aMPV/C was also isolated from farmed
ducks in France in 1999 [27] and in live bird market in
Korea in 2005 [28]. In 2000, it was reported that aMPVs
isolated in France in 1985 belong to subtype D [25].
In the field, aMPV/C leads to mild to severe, rapidly
spreading respiratory infection that can adversely
affect weight gain and feed conversion. The disease is. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lar discharge, and swollen infraorbital sinuses with
morbidity of up to 100% [29,30]. Microscopically,
inflammatory infiltrates (lymphocytes, macrophages,
plasma cells, and heterophils) were detected in nasal
turbinate and sinus tissues [31]. Mortality may reach
30% in cases complicated by secondary bacterial infec-
tion. Economic losses are due to mortality, a sharp
drop in egg production, and increased carcass condem-
nation rate at slaughter because of air sacculitis
[29,31].
The U.S. outbreaks of aMPV/C infection have oc-
curred in a seasonal pattern (spring and fall), and wild
migratory birds have been implicated in the spread of
the disease [32,33]. In fact, aMPV RNA was isolated
from the nasal turbinates of wild sparrows, geese, blue-
winged teal, and starlings and shown to share 90 to 95%
nucleotide sequence identity with viruses isolated from
domestic turkeys [15,32,33]. The role of wild birds in the
epidemiology of the disease and transmission of the
virus between commercial turkey farms is not clear. Se-
quence analysis at Southeast Poultry Research Labora-
tory (SEPRL) of four virus isolates recovered from
aMPV/C outbreaks in turkeys shared 95% to 99% nu-
cleotide sequence identity and 97% to 99% predicted
amino acid sequence identity with a duck virus isolated
from sentinel mallard ducks [34]. These results indicate
that aMPV/C isolates from turkeys and ducks share a
common source and the viruses from different avian
species can cross-infect other birds. In another study the
potential role of migratory waterfowl and other wild
birds in aMPV/C spread was also examined [35]. Those
results showed the presence of antibodies to aMPV/C in
American coots, American crows, Canada geese, cattle
egrets, and rock pigeons. When oral swabs were assayed
by using RT-PCR, aMPV RNA was detected in samples
from American coots and Canada geese. Sequence ana-
lysis indicated that the wild bird viruses belonged to
aMPV/C [35]. The data clearly demonstrated that wild
birds can serve as a reservoir of aMPV/C. While the
study showed that aMPV/C was able to replicate and in-
duce antibody production in wild birds, the pathogen-
icity of the aMPV/C isolates for domestic turkeys was
not determined [35]. The presence of a potentially
pathogenic virus among wild birds could eventually re-
sult in the introduction of aMPV/C into poultry flocks
in the U.S.
In this study, we determined the pathogenicity of wild
bird aMPV/C isolates in domestic turkeys. Biological
characteristics of the isolates were studied in vitro in cell
cultures and by sequence analysis of the G gene. The
virulence level and pathogenic properties of the wild
bird viruses were demonstrated in experimentally in-
fected SPF and commercial turkeys.Results
aMPV/C-P3 virus isolation from wild birds
Five out of 23 oral swabs from American coots (AC) and
7 out of 27 oral swabs from Canada geese (CG) were
found aMPV/C positive by using N and G gene specific
RT-PCR (data not shown). The positive swabs were
pooled (aMPV/C-AC-P0 and aMPV/C-CG-P0) and sub-
sequently passaged three times in the upper respiratory
tract of SPF turkeys, turbinate and tracheal samples were
processed as described in materials and methods. Virus
stocks from the third turkey passage were designated as
P3 viruses and titrated in CEF cultures. The titer of
aMPV/C-AC-P3 and aMPV/C-CG-P3 viruses were 104.5
TCID50/ml and 10
5 TCID50/ml, respectively. There was
no significant difference in growth characteristics and
virus yield in CEF cell cultures between the wild bird P3
viruses and the prototype virulent aMPV/C-CO Tr iso-
late (data not shown).
The G gene of aMPV/C wild bird isolates
Sequence analysis of the attachment (G) gene from the
virus positive AC-P0 pool showed the presence of mixed
G gene population that contained both full-length G
gene (759 nt) and variants of truncated G genes. The
size of the deletion within the truncated G open reading
frame (ORF) varied from 93 nt to 579 nt (Figure 1). Only
one major G gene fragment was detected within the
CG-P0 pool with a deletion of 582 nt (Figure 1). Follow-
ing three passages in turkeys the AC-P3 virus isolate
contained a dominant G gene ORF of 759 nt. This G
gene possesses the same length and sequences as that of
the Colorado strain reported by Lwamba et al. in 2005
[36]. There was no detectable full-length G gene in the
CG-P3 virus; instead a mixed population of shorter G
gene ORFs was present with a range of molecules con-
taining deleted segments from 126 nt to 279 nt. Some of
these G gene nucleotide deletions were in-frame sug-
gesting the presence of virus variants with truncated but
potentially functional G proteins.
Pathogenicity of wild bird isolates in turkey
In experiment 1, SPF turkeys were inoculated with
aMPV/C P3 isolates via ON route. From 5 DPI, the tur-
key poults exposed to either AC-P3 or CG-P3 viruses
exhibited typical clinical signs of aMPV/C disease, show-
ing nasal exudates when squeezed, nasal discharge, or
frothy eyes. These clinical signs were still apparent at 7
DPI but were not detectable at later times (Table 1). RT-
PCR data to detect viral RNA in tracheal swabs showed
that high percentage of inoculated birds became positive
at 3 DPI and the number of positives gradually declined
by 10 DPI. Microscopic lesions in the turbinate tissues
were only observed in a few birds (one positive in each
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Figure 1 Schematic representation of aMPV/C G gene from pooled American coot (AC) and Canada goose (CG) samples before (P0)
and after three serial turkey passages (P3). Nucleotide position is indicated by numbers according to GenBank submission of aMPV/C-US
strain [GenBank ID: AY579780.1]. Deletions within the G gene are represented by dotted lines and mapped by nucleotide numbers. Multiple
nucleotide positions indicate more than one deletion form within the same region of the aMPV/C-AC-P0 and aMPV/C-CG-P3 viruses.
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of turkeys infected with either AC or CG viruses (Table 1,
Figure 2). All birds inoculated with AC or CG viruses
developed aMPV/C specific antibody response by 14
DPI, while all sera collected from control birds were
negative.
In experiment 2, commercial turkeys were used to
study the pathogenic properties of aMPV/C wild bird
isolates along with turkeys infected with the challenge
virus aMPV/C-CO Tr. Clinical signs, viral RNA detec-
tion and seroconversion data following inoculation are
summarized in Table 2. Extensive aMPV/C diseaseTable 1 Pathogenicity of aMPV/C wild bird isolates in SPF tur
Inoculum aMPV/C RT-PCR Clinical signs
DPIa 3 5 7 10 5 7
Untreated 0/11b 0/11 0/9 0/7 0/11 0/9
aMPV/C-AC-P3 10/13 6/13 1/10 0/7 11/13 10/10
aMPV/C-CG-P3 6/12 2/12 0/8 1/4 9/12 5/8
a DPI, days post-inoculation.
b Number of positive birds per number in group.specific clinical signs were observed in all groups be-
tween 3 and 11 DPI and 100% of the birds seroconverted
by 14 DPI. Viral RNA was detectable in turkeys from
each group at 3 DPI; however, at later times positives
were only observed among the virulent challenge virus
inoculated birds. Microscopic lesions were much more
abundant in turbinate tissues than in tracheas in each
experimental group and IHC also demonstrated a more
pronounced virus replication in turbinates from each
group when they were compared to those observed in
trachea samples at 5 and 7 DPI (Table 3). Overall, both
wild bird P3 isolates exhibited very similar pathogenicitykeys (experiment 1)
Microscopic lesions IHC staining aMPV/C- ELISA
5 7 5 7 14 17
0/2 0/2 0/2 0/2 0/7 0/7
1/3 0/3 3/3 2/3 7/7 7/7
0/3 1/3 3/3 2/3 4/4 4/4
Figure 2 Detection of aMPV/C infected cells in the mucosal
layers of nasal turbinate from virus exposed SPF turkeys at 5
DPI by IHC staining. (a) Control untreated turkeys; (b) aMPV/C-AC-
P3 virus infected turkeys; (c) aMPV/C-CG-P3 virus infected turkeys.
Table 2 Pathogenicity of aMPV/C wild bird isolates in comme
Inoculum aMPV/C RT-PCR
DPIa 3 5 7 11
Untreated 0/10b 0/10 0/10 0/9
aMPV/C-AC-P3 4/10NS 0/10NS 0/10NS 0/10NS
aMPV/C-CG-P3 8/10NS 0/10NS 0/10NS 0/6NS
aMPV/C-CO- Tr 8/10 1/10 2/10 2/10
a DPI, days post-inoculation.
b Number of positive birds per number in group.
NS, statistically not significant difference.
*, p<0.01.
**, p<0.005.
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istics were compared to those detected following inocu-
lation with virulent virus aMPV/C-CO Tr.
Discussion
In the present study, we isolated avian metapneumo-
viruses from wild birds samples collected in 2000 from
Georgia, South Carolina and Arkansas in the U.S. Se-
quence analysis of virus isolates from oral swabs of
American coots and Canada geese confirmed that these
viruses belong to subtype C aMPV. Our data clearly
demonstrate that both AC and CG wild bird viruses
were fully pathogenic in SPF and commercial turkeys.
Following experimental inoculation, aMPV/C specific
clinical signs (with the exception at 3DPI), virus replica-
tion and shedding in the upper respiratory tract were in-
distinguishable in AC and CG virus infected birds from
those observed in group of turkeys inoculated with viru-
lent virus aMPV/C-CO Tr.
Wild birds have been considered as important reser-
voirs for other avian viruses such as avian influenza and
Newcastle disease viruses [37,38]. Previous studies in the
U.S. have shown the possible involvements of wild birds
in the transmission of aMPV/C viruses [15,32,33,39]. Re-
cent report revealed the presence of aMPV/C in wild
birds in the southeast regions of the U.S. [35]. Those
data demonstrated that wild birds can serve as a reser-
voir of subtype C aMPV and may provide a potential
mechanism to spread aMPVs to poultry. Here, our
results clearly demonstrate the possibility of virus trans-
mission from wild birds to domestic turkeys.
Conventional avian metapneumovirus isolation meth-
ods usually include several passages of the virus in avian
and mammalian cell cultures. While this technique is
convenient and routinely used to isolate virus from field
samples it has the potential risk that during serial pas-
sages in cell cultures the biological characteristics of the
virus, including genome structure and pathogenicity
could be altered. In fact, it is well documented that a
number of live attenuated aMPV vaccines were pro-
duced by passage of virulent virus in cell cultures andrcial turkeys (experiment 2)
Clinical signs aMPV/C- ELISA
3 5 7 11 14
0/23 0/19 0/13 0/9 0/9
11/21* 14/18NS 13/14NS 1/10NS 8/8
11/19** 14/18NS 11/12NS 0/6NS 5/5
4/24 12/22 12/15 3/10 10/10
Table 3 Immunohistochemistry (IHC) staining and microscopic lesions in commercial turkeys exposed to aMPV/C wild
bird P3 isolates (experiment 2)
Inoculum Turbinate Trachea
IHC staining Microscopic lesions IHC staining Microscopic lesions
DPIa 5 7 5 7 5 7 5 7
Untreated 0/4b 0/4 0/4 0/4 0/5 0/4 0/5 0/4
aMPV/C-AC-P3 4/4 4/4 2/4 4/4 2/4 1/4 0/4 0/4
aMPV/C-CG-P3 4/4 3/4 2/4 3/4 0/4 0/4 0/4 0/4
aMPV/C-CO-Tr 4/4 5/5 2/4 3/5 3/5 1/5 0/5 0/5
a DPI, days post-inoculation.
b Number of positive birds per number in group.
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icity were subsequently used as protective empirical vac-
cines [40-43]. It had also been reported that after 15 or
more Vero cell passages, the attachment G gene is
deleted from the genome of aMPV/C [44]. To avoid pos-
sible genomic alterations and/or attenuation following
serial virus passage in cell cultures, our studies have fo-
cused on the isolation of aMPV/C viruses from wild
birds using in vivo method. Serial passages of aMPV/C
in turkeys proved to be a highly efficient technique to
prepare virulent challenge viruses in past studies [45,46].
In our studies, three serial passages of RT-PCR positive
wild bird oral swab samples in the respiratory tract of
SPF turkeys resulted in the isolation of aMPV/C-P3
viruses without having them propagated in cell cultures.
It is important to note that the AC-P3 and CG-P3 iso-
lates exhibited similar growth characteristics in vitro in
CEF cell cultures when cytopathic effect and virus yields
were compared to those observed in cultures infected
with virulent aMPV/C-CO Tr virus. These data indi-
cated that using the wild bird P3 isolates in subsequent
experiments in turkeys provided true and relevant infor-
mation about the pathogenic properties of aMPV/C
viruses carried by wild birds in nature.
aMPV G gene encodes a major structural glycoprotein
that plays important role in viral attachment, pathogen-
icity and protective immunity [45,47]. The G protein of
aMPV isolates exhibits extensive genetic and antigenic
variations that are the primary criteria for aMPV subtype
classification [7,48,49]. The G gene in aMPV/C isolates
exhibits major sequence divergence and the length of
the genome reported for different aMPV/C strains iso-
lated in the U.S. is strikingly different [32,36,50,51]. Al-
though recent studies indicated that truncation of the G
genes can occur during serial passages of the virus in cell
cultures or circulation of the virus in a host in the field
[44,52] the biological significance of the G gene length
variation is mostly unknown. Our data provide further
evidence that the G protein may play an important role
in viral pathogenesis in domestic turkey. While the ori-
ginal pooled wild bird samples contained a mixture ofvirus population with mostly truncated G genes with
large deletions, following three passages in turkey the P3
virus stocks contained either full-length G gene (AC-P3)
or truncated G genes (CG-P3) with in-frame deletions.
It is tempting to speculate that while the G gene may
not play important role for aMPV/C replication in wild
birds, it is required for efficient virus growth in turkeys.
This hypothesis is supported by recent studies, which
showed that deletion of the G gene from virulent
aMPV/C viruses resulted in attenuation of the virus in
turkeys [45,47].
In conclusion, we successfully demonstrated that
aMPV/C viruses carried by wild birds in the U.S. possess
a potential threat to commercial turkeys. These wild bird
viruses are fully virulent and capable of initiating aMPV/
C disease outbreaks in susceptible flocks by direct trans-
mission of the virus between wild birds and turkeys.
This finding provides further and more definite reason
of maintaining high biosecurity standard in the poultry
industry.
Materials and methods
Viruses and cell cultures
The aMPV/C Colorado strain from turkeys (aMPV/CO/
96/C) was obtained from the aMPV repository bank at
SEPRL (USDA-ARS, Athens, GA, USA). The virus was
propagated in Vero cells (ATCC, Manassas, VA, CCL-
81). A virulent challenge virus stock aMPV/C-CO Tr
was prepared by three consecutive in vivo passages of
the aMPV/CO/96/C in turkeys as previously described
[45] and was titrated in 1-week-old turkeys for 50% in-
fective dose (ID50). Oral swabs from wild birds [American
coot (AC) (n=23) and Canada goose (CG)] (n=27)
were obtained from SEPRL collection and tested for
aMPV/C by reverse transcriptase-polymerase chain re-
action (RT-PCR) as described in previous studies [44].
Virus positive swabs from each wild bird were pooled,
labeled as P0 (aMPV/C-AC-P0, n=5; aMPV/C-CG-P0,
n=7), and inoculated via oculonasal (ON) route to 3-
day-old SPF turkeys at a dose of 200 μl inoculum per
bird. At 5 days post-inoculation (DPI), turbinate and
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pared with 1x phosphate buffered saline (PBS). Two
more passages were repeated in the same manner in 3-
day-old SPF turkeys to obtain P3 stock virus of each wild
bird isolate (aMPV/C-AC-P3; aMPV/C-CG-P3). To rule
out the possibility of the presence of avian influenza
virus (AIV) and Newcastle disease virus (NDV) in the
P3 isolates, 9-day-old embryonating chicken eggs were
inoculated with the P3 stock viruses and after three
blind passages hemagglutination assays were performed
from the chorioallantoic fluids as described previously
[37,45]. Both aMPV/C-AC and aMPV/C-CG P3 isolates
were negative to AIV and NDV (data not shown).
Virus titration was performed as previously described
[45] with some modification. Briefly, 96-well plates were
seeded with SPF chicken embryo fibroblast (CEF) cells
and infected with 100 μl of serial 10-fold dilutions of the
viruses. After 4–5 days of incubation at 37°C, plates were
fixed with 100% ethanol and indirect fluorescence assay
was performed using aMPV/C hyperimmune turkey
serum. Titers were calculated by the Reed and Muench
method [53] and are expressed as 50% tissue culture in-
fective dose (TCID50). Virus growth was examined in
CEF cell cultures at 0.01 multiplicity of infection (MOI).
At 4 days post-infection, the monolayers were harvested
and virus was titrated as described above.
RT-PCR
RNA was extracted from oral or tracheal swabs using
Viral RNA Extraction Kit (Qiagen, Valencia, CA) and
one-step RT-PCR was performed with a Superscript III
one-step RT-PCR Kit (Invitrogen, Carlsbad, CA), follow-
ing the manufacturer’s protocol. aMPV/C N gene-
specific primers were designed based on gene sequence
in GenBank [GenBank ID: AM293284] [45]and primers
to detect aMPV/C G gene were used as previously
described [44]. The sequence of aMPV/C N gene for-
ward primer was 5’-ATGTCTCTTCAGGGGATTC-3’
and reverse primer was 5’-GCATCATTCAGCACACG-
3’, the expected size of the amplicon was 650 bp.
Nucleotide sequencing
aMPV/C G gene specific RT-PCR products were sepa-
rated in ethidium bromide agarose gel, fragments of
expected size were excised and DNA was extracted using
a Qiagen MinElute Kit (Qiagen, Valencia, CA). Purified
DNA was ligated into the TOPO PCR 2.1 cloning Vector
(Invitrogen, Carlsbad, CA) and was used to transform
DH5α competent cell (Invitrogen, Carlsbad, CA). Col-
onies were incubated in LB broth (containing kanamy-
cin) and DNA was prepared using plasmid miniprep
purification kit (5 PRIME Inc., Gaithersburg, MD). Se-
quencing was performed with M13 universal forward
and reverse primers using the Applied Biosystems-PRISM fluorescent big dye sequencing kit and the ABI
3730 automated DNA sequencer (ABI, Foster City,
CA). The sequence obtained from each colony was
compared and analyzed with those in the GenBank
using the BLAST algorithms and DNASTAR program
(Madison, WI).
Animal experimental design
SPF turkeys were obtained from the SEPRL flocks,
aMPV/C antibody-free hybrid commercial turkeys were
received from Prestige farm (Charlotte, NC). The birds
were housed in Horsfal isolators (Federal Designs, Inc.,
Comer, GA) with ad libitum access to feed and water.
Sera from one-day-old turkeys (n=10) were examined by
aMPV/C-specific enzyme-linked immunosorbent assay
(ELISA) to ensure the absence of anti-aMPV/C anti-
bodies. All experimental procedures in turkeys were
approved by the SEPRL Institutional Animal Care and
Use Committee.
In experiment 1, four-day-old SPF turkeys were
divided into three groups of 15 birds. Birds in group 1
were untreated and served as negative controls. Birds in
groups 2 and 3 were inoculated via oronasal (ON) route
with 200 μl of aMPV/C-AC-P3 (104.5 TCID50/ml) and
aMPV/C-CG-P3 (105 TCID50/ml), respectively. At 3, 5,
7 and 10 DPI, tracheal swabs were collected (from all
available in each group, n=4-13) and clinical signs for
aMPV disease were observed as described previously
[45]. Turkeys were considered clinically positive if show-
ing nasal exudates when squeezed, nasal discharge or
frothy eyes. Turbinate and trachea tissues for histopath-
ology and immunohistochemistry (IHC) were randomly
collected at 5 and 7 DPI (n=2 from controls and n=3
from inoculated) and serum to detect virus specific anti-
bodies was collected at 14 DPI (n=7 from control and
AC group; n=4 from CG group).
In experiment 2, three-day-old aMPV/C antibody free
commercial turkeys were randomly divided into four
groups of 25 birds and inoculated via ON routes as
described in experiment 1. Birds in group 1 were un-
treated, birds in group 2 and 3 received aMPV/C-AC-P3
and aMPV/C-CG-P3, respectively. Each bird in group 4
was infected with 200 μl aMPV/C-CO Tr (104.6 ID50/ml)
via ON route as a positive control. At 3, 5, 7 and 11
DPI, tracheal swabs were collected (n=10) and the birds
were observed for recording aMPV clinical signs. Tur-
binate and trachea tissues for histopathology and IHC
(n=4-5) were randomly collected at 5 and 7 DPI and
serum samples (n=5-9) for aMPV/C specific ELISA were
collected at 14 DPI.
Histopathology and immunohistochemistry
For histopathology, turbinate and trachea tissues were
fixed in formalin and embedded in paraffin. Sections
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and eosin (HE). All HE stained sections were examined
by light microscope. Turkeys were considered positive if
extensive lymphoid cell infiltrations were observed in
the mucosal layer of turbinate or trachea as shown in
previous reports [31,54,55]. Virus infected cells were
detected by IHC staining as previously described with
some modifications [56,57]. Briefly, paraffin embedded
sections (4 μm) of turbinate or trachea tissues were
deparaffinized, dehydrated followed by antigen retrieval
with citrate buffer (Biogenex, San Ramon, CA). Rabbit
anti-aMPV/C hyperimmune serum (kindly provided by
Dr. K. Nagaraja of University of Minnesota) was used as
primary antibody in1:1000 dilution. For secondary anti-
body, goat anti-rabbit IgG conjugated with horseradish
peroxidase (HRP) (KPL, Gaithersburg, MD) was used at
dilution of 1:250. The signal was developed with 3'-dia-
minobenzidine (DAB) Kit (Vector Laboratory, Burlin-
game, CA) following manufacturer’s instruction.
ELISA
Anti-aMPV/C antibody response of turkeys was deter-
mined by an aMPV/C-specific IgG ELISA as previously
described [45]. Briefly, turkey sera were diluted (1:100)
and added to 96-well plates in triplicates, which were
coated with sucrose gradient purified aMPV/CO/96/C
virus as antigen. HRP conjugated goat anti-turkey IgG
antibody (KPL, Gaithersburg, MD) was added as second-
ary antibody. A luminal-based chemiluminescent sub-
strate (Lumiglo substrate kit; KPL, Gaithersburg, MD)
was used as a developing agent. The chemiluminescence
relative light unit (RLU) was measured on a Biotek Syn-
ergy HT Microtiter Plate Luminometer (Biotek Instru-
ments, Winooski, VT). Test sera were considered
positive when the mean RLU value was higher than the
mean RLU plus 2 × standard deviation of the negative
turkey serum pool.
Statistics
The statistical analyses were done using the Fisher’s
exact test (SigmaStat 2.0.3, SPSS Inc, Chicago, IL) in Ex-
periment 2, where groups of turkeys inoculated with
aMPV/C-AC-P3 or aMPV/C-CG-P3 viruses were com-
pared to those infected with virulent aMPV/C-CO-Tr
challenge virus.
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